TCI Wealth Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15
Closed -$94 990
2023
Q1
$94 Hold
15
﹤0.01% 2402
2022
Q4
$70 Hold
15
﹤0.01% 2418
2022
Q3
$0 Hold
15
﹤0.01% 2365
2022
Q2
$0 Hold
15
﹤0.01% 2358
2022
Q1
$0 Hold
15
﹤0.01% 2297
2021
Q4
$0 Hold
15
﹤0.01% 2367
2021
Q3
$1K Hold
15
﹤0.01% 2263
2021
Q2
$1K Hold
15
﹤0.01% 2211
2021
Q1
$1K Buy
+15
New +$675 ﹤0.01% 2065

Other funds holding GDRX

TCI Wealth Advisors's GDRX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of GoodRx Holdings (GDRX) in Q2 2023, closing a stake of 15 shares — an estimated $94 sold.

TCI Wealth Advisors first reported a position in GDRX in Q1 2021 and held it in 9 quarters. The position peaked at $1K in Q3 2021. 147 funds tracked by Wall St. Rank hold GDRX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining GoodRx Holdings position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 15 GoodRx Holdings shares in Q2 2023, an estimated $94.
  • TCI Wealth Advisors first reported a position in GoodRx Holdings in Q1 2021 and held it in 9 quarters.
  • TCI Wealth Advisors's GoodRx Holdings position peaked at $1K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.